Using ketamine in a pediatric patient with a pain crisis in juvenile idiopathic arthritis. A case report

  • Cristina Posada-Giraldo Pain Relief Clinic, Clínica Universitaria Bolivariana, Universidad Pontificia Bolivariana, Medellín, Colombia.
  • María Alejandra Herrera-Mondragón Pain Relief Clinic, Clínica Universitaria Bolivariana, Universidad Pontificia Bolivariana, Medellín, Colombia.
  • William Henry Joaquí-Tapia Pain Relief Clinic, Clínica Universitaria Bolivariana, Universidad Pontificia Bolivariana, Medellín, Colombia.
Keywords: Ketamine, Arthritis Juvenile, Chronic Pain, Case Reports, Anesthesia

Abstract

Introduction:

Ketamine has been used as a pain management strategy, particularly in adults. There are some clinical data about the use of Ketamine in children but there are no reports referring to its efficacy, specifically in juvenile idiopathic arthritis. Ketamine could therefore become an alternate option in the management of refractory cases.

Clinical findings:

This report discusses the case of a 7-year-old male patient with a history of juvenile idiopathic arthritis who was admitted to the hospital as a result of an inflammatory pain crisis associated with stiff hands and feet, pain, edema, and enthesitis, in addition to signs of bilateral sacroiliitis, stiffness impairing gait, passive and active movements, poor response to multimodal analgesia with nonsteroidal antiinflammatory drugs, steroids and weak opioids. Adequate pain control and significant improvement of the child’s function was achieved after initiating ketamine infusion at analgesic doses.

Conclusions:

This case provides valuable information about the usefulness of ketamine as a modulator of central sensitization and inflammation that could be extrapolated to a similar population of rheumatology patients.

References

1. Pérez Gómez A, Sánchez Atrio AI, Albarrán Hernández F, Cuende Quintana E. Artritis idiopática juvenil. Medicine - Programa de Formación Médica Continuada Acreditado 2009;10:1933-1941.

2. Blazina S, Markelj G, Avramovic MZ, Toplak N, Avcin T. Management of Juvenile Idiopathic Arthritis: A Clinical Guide. Paediatr Drugs 2016;18:397-412.

3. Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet 2007; 369:767-778.

4. Berde CB, Sethna NF. Analgesics for the treatment of pain in children. N Engl J Med 2002;347:1094-1103.

5. Modesto C, Woo P, García-Consuegra J, Merino R, García Granero M, Arnal C, et al. Systemic onset juvenile chronic arthritis, polyarticular pattern and hip involvement as markers for a bad prognosis. Clin Exp Rheumatol 2001;19:211-217.

6. Bredlau AL, Thakur R, Korones DN, Dworkin RH. Ketamine for pain in adults and children with cancer: a systematic review and synthesis of the literature. Pain Med 2013;14:1505-1517.

7. Sheehy KA, Muller EA, Lippold C, Nouraie M, Finkel JC, Quezado ZMN. Subanesthetic ketamine infusions for the treatment of children and adolescents with chronic pain: a longitudinal study. BMC Pediatr 2015;15:198.

8. Sawyer MG, Carbone JA, Whitham JN, Roberton DM, Taplin JE, Varni JW, et al. The relationship between health-related quality of life, pain, and coping strategies in juvenile arthritis-a one year prospective study. Qual Life Res 2005;14:1585-1598.

9. Dale O, Somogyi AA, Li Y, Sullivan T, Shavit Y. Does intraoperative ketamine attenuate inflammatory reactivity following surgery? A systematic review and meta-analysis. Anesth Analg 2012;115: 934-943.

10. Minoshima R, Kosugi S, Nishimura D, Ihara N, Seki H, Yamada T, et al. Intra- and postoperative low-dose ketamine for adolescent idiopathic scoliosis surgery: a randomized controlled trial. Acta Anaesthesiol Scand 2015;59:1260-1268.

11. Wu G, Chen T, Ueng Y, Chen R. Ketamine inhibits tumor necrosis factor-( and interleukin-6 gene expressions in lipopolysaccharide-stimulated macrophages through suppression of toll-like receptor 4-mediated c-Jun N- terminal kinase phosphorylation and activator protein-1 activation. Toxicol Appl Pharmacol 2008;228: 105-113.

12. Bredlau AL, Harel BT, McDermott MP, Dworkin RH, Korones DN, Dolan JG, et al. Neurocognitive changes after sustained ketamine administration in children with chronic pain. J Palliat Care Med 2015;5:215.

13. Finkel JC, Pestieau SR, Quezado ZMN. Ketamine as an adjuvant for treatment of cancer pain in children and adolescents. J Pain 2007;8:515-521.

14. Taylor M, Jakacki R, May C, Howrie D, Maurer S. Ketamine PCA for treatment of end-of-life neuropathic pain in pediatrics. Am J Hosp Palliat Care 2015;32:841-848.

15. Loix S, De Kock M, Henin P. The anti-inflammatory effects of ketamine:state of the art. Acta Anaesthesiol Belg 2011;62: 47-58.

16. Cadavid A, Rodelo K, Medina P, Sánchez A. Efecto de adicionar Ketamina a la morfina en analgesia controlada por el paciente (PCA) en un modelo de laparotomía. Rev Colomb Anestesiol 2008;36:19-24.

17. Dahmani S, Michelet D, Abback P-S, Wood C, Brasher C, Nivoche Y, et al. Ketamine for perioperative pain management in children: a meta-analysis of published studies. Paediatr Anaesth 2011;21: 636-652.
How to Cite
1.
Posada-Giraldo C, Herrera-Mondragón MA, Joaquí-Tapia WH. Using ketamine in a pediatric patient with a pain crisis in juvenile idiopathic arthritis. A case report. Colomb. J. Anesthesiol. [Internet]. 2018 Dec. 1 [cited 2024 Feb. 23];46(Supplement):69-72. Available from: https://www.revcolanest.com.co/index.php/rca/article/view/147

Downloads

Download data is not yet available.
Published
2018-12-01
How to Cite
1.
Posada-Giraldo C, Herrera-Mondragón MA, Joaquí-Tapia WH. Using ketamine in a pediatric patient with a pain crisis in juvenile idiopathic arthritis. A case report. Colomb. J. Anesthesiol. [Internet]. 2018 Dec. 1 [cited 2024 Feb. 23];46(Supplement):69-72. Available from: https://www.revcolanest.com.co/index.php/rca/article/view/147
Section
Case Report / Case Series

Altmetric

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views
QR Code

Some similar items: